What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Schizophrenia
His primary areas of investigation include Psychiatry, Schizophrenia, Antipsychotic, Olanzapine and Internal medicine.
His biological study spans a wide range of topics, including Clinical trial and Clinical psychology.
His Schizophrenia research includes elements of Psychosis, Bipolar disorder, Meta-analysis, Dopamine and Neurocognitive.
The study incorporates disciplines such as Aripiprazole, Quetiapine, Tolerability, Intensive care medicine and Pharmacology in addition to Antipsychotic.
His Olanzapine study integrates concerns from other disciplines, such as Anesthesia, Risperidone, Clozapine and Atypical antipsychotic.
Leslie Citrome has included themes like Placebo and Endocrinology in his Internal medicine study.
His most cited work include:
- Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder (459 citations)
- Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics (385 citations)
- Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder (341 citations)
What are the main themes of his work throughout his whole career to date?
Leslie Citrome mostly deals with Psychiatry, Antipsychotic, Schizophrenia, Internal medicine and Olanzapine.
His work deals with themes such as Number needed to treat and Clinical psychology, which intersect with Psychiatry.
His Antipsychotic study incorporates themes from Aripiprazole, Anesthesia, Pediatrics and Pharmacology.
The various areas that Leslie Citrome examines in his Schizophrenia study include Bipolar disorder, Psychosis, Randomized controlled trial, Hostility and Dosing.
His Internal medicine research is multidisciplinary, relying on both Placebo, Akathisia and Positive and Negative Syndrome Scale.
His research in Olanzapine intersects with topics in Haloperidol, Dopamine antagonist, Risperidone and Clozapine.
He most often published in these fields:
- Psychiatry (52.50%)
- Antipsychotic (33.64%)
- Schizophrenia (30.50%)
What were the highlights of his more recent work (between 2016-2021)?
- Psychiatry (52.50%)
- Internal medicine (28.84%)
- Antipsychotic (33.64%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Psychiatry, Internal medicine, Antipsychotic, Schizophrenia and Placebo.
The Internal medicine study combines topics in areas such as Akathisia and Positive and Negative Syndrome Scale.
His work carried out in the field of Antipsychotic brings together such families of science as Pharmacokinetics, Pharmacology and Pediatrics.
The concepts of his Schizophrenia study are interwoven with issues in Clinical trial and Intensive care medicine.
His Placebo study combines topics in areas such as Extrapyramidal symptoms, Exacerbation, Cariprazine, Adverse effect and Post-hoc analysis.
As a member of one scientific family, Leslie Citrome mostly works in the field of Paliperidone, focusing on Schizoaffective disorder and, on occasion, Aripiprazole.
Between 2016 and 2021, his most popular works were:
- Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology (301 citations)
- Investigational drugs in recent clinical trials for treatment-resistant depression. (39 citations)
- Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm. (38 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Law
Leslie Citrome mainly investigates Antipsychotic, Psychiatry, Schizophrenia, Internal medicine and Placebo.
His research integrates issues of Deutetrabenazine, Valbenazine, Tardive dyskinesia and Intensive care medicine in his study of Antipsychotic.
In his study, Randomized controlled trial, Anorexia nervosa, Nausea and Clozapine is inextricably linked to Olanzapine, which falls within the broad field of Intensive care medicine.
In general Psychiatry study, his work on Binge-eating disorder, Comorbidity and Abnormality often relates to the realm of Differential diagnosis and Social stigma, thereby connecting several areas of interest.
His Schizophrenia research includes themes of Psychosis and Clinical trial.
His study in Internal medicine is interdisciplinary in nature, drawing from both Bipolar I disorder, Treatment-resistant depression and Positive and Negative Syndrome Scale.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
